Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Janssen-cilag International Nv

Clinical trials sponsored by Janssen-cilag International Nv, explained in plain language.

Now part of Johnson & Johnson JNJ NYSE

Pharmaceutical subsidiary of Johnson & Johnson.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 1

Psoriasis drug stelara under safety watch in kids

Disease control Ongoing

This study follows 135 children aged 6 to 17 with moderate to severe plaque psoriasis who are already starting or have recently started treatment with ustekinumab (Stelara). Researchers are monitoring for serious side effects like infections, cancer, and autoimmune issues, as wel…

Sponsor: Janssen-Cilag International NV • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC